Project 1. Robust-to-fragile transitions of a phase-separated mitotic organelle in triple-negative breast cancer

Project 1. Robust-to-fragile transitions of a phase-separated mitotic organelle in triple-negative breast cancer

This project examines phase separation-mediated organellogenesis of the chromosome passenger complex during metaphase in a breast cancer subtype that is prone to aneuploidy.

Read more.


Project 2. A systems-metabolism approach to identify mitochondria-dependent vulnerabilities in colorectal cancer

Project 2. A systems-metabolism approach to identify mitochondria-dependent vulnerabilities in colorectal cancer

This project investigates the metabolic-network consequences of mitochondrial fragmentation in RAS-mediated colorectal cancer and the associated microbiome.

Read more.


Project 3. EGFR signaling network adaptations to overcome RAS-induced membrane stress in glioblastoma

Project 3. EGFR signaling network adaptations to overcome RAS-induced membrane stress in glioblastoma

This project evaluates the role of mutant EGFRvIII in alleviating cell death by methuosis (excessive macropinocytosis) in glioblastomas with hyperactivation of RAS.

Read more.


Cross-Consortium Research Project – Yr3 – “Transition zones in solid tumors and precancers”

Cross-Consortium Research Project – Yr3 – “Transition zones in solid tumors and precancers”

Allison May, MD, UVa Health Department of Urology, Kevin Janes, PhD, UVa Biomedical Engineering, Andrew Gentles, PhD, Stanford University Departments of Pathology, Medicine and Biomedical Data Science

Read more.